Experimental Ebola drugs including compounds from Mapp Biopharmaceutical, Sarepta and Tekmira will be tested in affected West African states for the first time in a bid to fast-track trials, the Wellcome Trust said on Tuesday.
Ebola drug trials to be fast-tracked in West Africa
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.